Barcelona 2002: Taking Stock of the Epidemic
By Patricia Kahn and Emily Bass
In the high-stakes world of AIDS research, two years can bring distinct shifts in priorities and paradigms.
Vol. 06, No. 3, May-June 2002
Barcelona 2002, IAVI Establishes HIV Neutralizing Antibody Consortium, Learning from Microbicides, Update on HIV/AIDS and Vaccines, New Vaccine Trial Site in Brazil, New Models for Vaccine Delivery, Vaccine Briefs
Community Advocates Spur Effort to Establish New Vaccine Trial Site in Brazil
By Alexandre do Valle Menezes and Ronaldo Mussauer de Lima
From 2-4 May 2002, a group of AIDS community advocates, government policymakers and others involved with HIV/AIDS met in the southern Brazilian town of Santa Cruz do Sul to begin forging plans for launch a vaccine trial site in their region.
IAVI Establishes HIV Neutralizing Antibody Consortium
By Emily Bass
IAVI, the National Institutes of Health Vaccine Research Center (VRC) and a number of leading laboratories have formed an HIV Neutralizing Antibody Consortium (NAC) that will intensify work on one of the AIDS vaccine field’s most enduring challenges:
India's Political Leadership Gathers for Update on HIV/AIDS and Vaccines
By Subhadra Menon
Here in the world’s most populous democracy, rival political parties seldom show unity, whatever the cause.
Injecting Drug Users and HIV Vaccine Trials
What Does the Science Say?
Learning from Microbicides
A Young Field's Experience Working with High-Risk Women
New Models for Vaccine Delivery
An Interview with Tore Godal
When the Global Alliance for Vaccines and Immunizations (GAVI) was founded in 2000, it pioneered a new model for accelerating the delivery of public health commodities to developing countries.
Vaccine Briefs
US Congress Proposes Major Increase in Funds for Global AIDS